AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,025 | -96.7% | 28,596 | -19.0% | 0.00% | -100.0% |
| Q2 2020 | $479,000 | +74.2% | 35,294 | -2.7% | 0.00% | 0.0% |
| Q1 2020 | $275,000 | +25.0% | 36,285 | +4.4% | 0.00% | – |
| Q4 2019 | $220,000 | +73.2% | 34,759 | +6.9% | 0.00% | – |
| Q3 2019 | $127,000 | -21.6% | 32,525 | -3.0% | 0.00% | – |
| Q2 2019 | $162,000 | -41.7% | 33,548 | -1.3% | 0.00% | -100.0% |
| Q1 2019 | $278,000 | +78.2% | 33,988 | +20.3% | 0.00% | – |
| Q4 2018 | $156,000 | -33.9% | 28,263 | +5.6% | 0.00% | -100.0% |
| Q3 2018 | $236,000 | +21.6% | 26,763 | +37.6% | 0.00% | 0.0% |
| Q2 2018 | $194,000 | -44.6% | 19,449 | -17.4% | 0.00% | 0.0% |
| Q4 2017 | $350,000 | +288.9% | 23,559 | +134.1% | 0.00% | 0.0% |
| Q1 2017 | $90,000 | -16.7% | 10,062 | -2.6% | 0.00% | 0.0% |
| Q4 2016 | $108,000 | +14.9% | 10,332 | -1.6% | 0.00% | 0.0% |
| Q3 2016 | $94,000 | – | 10,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |